Skip to content

Bristol-Myers Squibb

US · BMY #158 by market cap Listed 1970
58.80 +0.46 +0.79%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
B+
Momentum strategy signal
Sell
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Improving
2
■ Upgrades■ Downgrades
  • 2 upgrades vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Argus Research moved from Hold to Buy on 2026-08-04.

Analyst consensus 17 analysts

Buy
Avg price target 67.25 +14.4%
Price target rangecurrent 58.80
Low40.00
Avg67.25
High80.00
Buy 47% Hold 47% Sell 6%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-16 Barclays -- Buy 75.00
2026-10-30 Morgan Stanley -- Sell 40.00
2026-10-29 William Blair -- Hold --
2026-10-29 BofA Securities -- Buy 67.00
2026-10-29 Guggenheim -- Buy 75.00
2026-10-29 Barclays -- Buy 75.00
2026-10-29 RBC Capital -- Hold 64.00
2026-10-27 Piper Sandler -- Buy 78.00
2026-10-27 RBC Capital -- Hold 64.00
2026-10-26 Piper Sandler -- Buy 78.00
2026-10-19 Goldman Sachs -- Hold 63.00
2026-10-19 RBC Capital -- Hold 64.00
2026-10-16 RBC Capital -- Hold 64.00
2026-10-13 Wells Fargo -- Hold 60.00
2026-10-13 Piper Sandler -- Buy 82.00
2026-10-13 Truist Financial -- Buy 70.00
2026-10-13 Citi -- Hold 70.00
2026-10-13 Barclays -- Buy 75.00
2026-10-12 William Blair -- Hold --
2026-10-12 Morgan Stanley -- Sell 41.00
2026-10-12 Jefferies -- Buy 76.00
2026-10-12 BMO Capital -- Hold 60.00
2026-10-12 Goldman Sachs -- Hold 63.00
2026-10-12 RBC Capital -- Hold 64.00
2026-10-09 UBS -- Buy 80.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-08-04 Argus Research Hold → Buy 75.00
2025-12-15 BofA Securities Hold → Buy 61.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-29 -- ±3.49% +1.35% (in line)
2026/Q2 2026-07-30 -- ±3.20% +2.79% (in line)
2026/Q1 2026-04-30 -- ±4.05% +5.21% (beat)
2025/Q4 2026-02-05 -- ±3.69% +3.30% (in line)
2025/Q3 2025-10-30 -- ±4.33% +7.09% (beat)
2025/Q2 2025-07-31 -- ±4.93% -5.81% (beat)
2025/Q1 2025-04-24 -- ±5.27% +0.33% (in line)
2024/Q4 2025-02-06 -- ±5.62% -3.84% (in line)
2024/Q3 2024-10-31 -- ±4.48% +5.91% (beat)
2024/Q2 2024-07-26 -- ±6.00% +11.44% (beat)
2024/Q1 2024-04-25 -- ±3.57% -8.51% (beat)
2023/Q4 2024-02-02 -- ±5.14% +0.08% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:42 · For reference only, not investment advice and not tailored to your situation.

Bristol-Myers Squibb discussion 0 comments

Add a comment